MedEquities Realty Trust Receives a Buy from FBR Capital

By Ryan Adsit

FBR Capital analyst Bryan Maher reiterated a Buy rating on MedEquities Realty Trust (NYSE: MRT) on November 8. The company’s shares closed yesterday at $11.19.

According to, Maher is a 1-star analyst with an average return of -3.2% and a 42.1% success rate. Maher covers the Financial sector, focusing on stocks such as Government Properties Income Trust, Retail Opportunity Investments, and Ashford Hospitality Trust.

MedEquities Realty Trust has an analyst consensus of Moderate Buy.

MedEquities Realty Trust’s market cap is currently $125.9M and has a P/E ratio of 291.41. The company has a book value ratio of 0.4781.

MedEquities Realty Trust, Inc. operates as a real estate investment trust. It focuses on investment in healthcare properties and healthcare related real estate debt investments. It owns, develops, operates, leases, and disposes healthcare properties and portfolios. The company was founded in April 23, 2014 and is headquartered in Nashville, TN.